ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.53
1.40%
US Tech 100
17,602.80
1.05%
S&P 500
5,180.74
1.03%
US Dollar vs CAD
1.36689
-0.17%
Bitcoin
63,394.53
-0.94%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Veracyte Inc (VCYT)

  7. Veracyte Inc (VCYT) News

VCYT Veracyte Inc

20.92
0.57 (2.80%)
After Hours
Last Updated: 16:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Veracyte Inc VCYT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.57 2.80% 20.92 16:30:00
Open Price Low Price High Price Close Price Previous Close
20.39 20.39 21.16 20.92 20.35
more quote information »

Recent News

Date Time Source Heading
5/06/202415:05BW14 Studies Presented at AUA 2024 Show Decipher Tests’..
4/22/202416:00BWVeracyte to Release First Quarter 2024 Financial Results on..
4/22/202407:30BWNew Study Shows Veracyte’s Decipher Prostate Test is..
4/16/202407:30BWVeracyte Announces that Nine Studies Reinforcing the Value..
3/08/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:27EDGAR2Form 8-K - Current report
2/29/202416:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
2/29/202416:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/29/202415:40EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2/29/202407:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/202416:55BWVeracyte’s Decipher Prostate Test Receives Highest..
2/22/202415:12EDGAR2Form 8-K - Current report
2/22/202415:05BWVeracyte Announces Fourth Quarter and Full-Year 2023..
2/21/202416:00BWVeracyte to Participate in the Raymond James 45th Annual..
2/13/202415:15EDGAR2Form 8-K - Current report
2/08/202407:00BWVeracyte to Release Fourth Quarter and Full-Year 2023..
2/06/202407:23EDGAR2Form 8-K - Current report
2/06/202407:15BWVeracyte Completes Acquisition of C2i Genomics
1/29/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/08/202407:12EDGAR2Form 8-K - Current report
1/08/202407:00BWVeracyte Announces Preliminary Full-Year 2023 Results,..
12/12/202315:30BWVeracyte to Participate in the 42nd Annual J.P. Morgan..
12/05/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202315:05BWReal-World Data Presented at SUO 2023 Show that Veracyte’s..
11/29/202307:30BWClinical Validation Data Published in CHEST Demonstrate that..
11/22/202307:30BWVeracyte Announces Seven Posters Highlighting Clinical Value..
11/08/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:09EDGAR2Form 8-K - Current report
11/07/202315:05BWVeracyte Announces Third Quarter 2023 Financial Results
11/07/202315:00BWVeracyte Announces In Vitro Diagnostic Agreement with..
11/02/202307:15BWVeracyte to Participate in the Stephens Annual Investment..
10/27/202307:30BWVeracyte Announces SITC 2023 Presentations Offering New..
10/17/202307:15BWVeracyte to Release Third Quarter 2023 Financial Results on..
10/12/202308:00BWNew Data Presented at CHEST 2023 Demonstrate the Clinical..
10/04/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202315:31EDGAR2Form 3 - Initial statement of beneficial ownership of..

Your Recent History

NASDAQ
VCYT
Veracyte
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved